USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 78,129 shares of USANA Health Sciences stock in a transaction that occurred on Friday, March 9th. The stock was sold at an average price of $81.19, for a total transaction of $6,343,293.51. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
USANA Health Sciences, Inc. (NYSE USNA) traded down $0.45 during mid-day trading on Monday, reaching $80.70. 181,670 shares of the company were exchanged, compared to its average volume of 99,355. The firm has a market cap of $1,950.00, a PE ratio of 21.46 and a beta of 0.94. USANA Health Sciences, Inc. has a one year low of $52.55 and a one year high of $81.90.
USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, February 6th. The company reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.11. The company had revenue of $273.11 million during the quarter, compared to analysts’ expectations of $258.67 million. USANA Health Sciences had a net margin of 5.97% and a return on equity of 27.08%. USANA Health Sciences’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period last year, the business earned $0.87 EPS. sell-side analysts predict that USANA Health Sciences, Inc. will post 4.25 EPS for the current year.
A number of hedge funds have recently added to or reduced their stakes in the stock. California State Teachers Retirement System boosted its stake in USANA Health Sciences by 0.5% in the 2nd quarter. California State Teachers Retirement System now owns 20,582 shares of the company’s stock worth $1,319,000 after purchasing an additional 100 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in USANA Health Sciences by 7.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 9,137 shares of the company’s stock worth $586,000 after purchasing an additional 616 shares in the last quarter. Voya Investment Management LLC boosted its stake in USANA Health Sciences by 13.4% in the 2nd quarter. Voya Investment Management LLC now owns 5,712 shares of the company’s stock worth $366,000 after purchasing an additional 676 shares in the last quarter. Allianz Asset Management GmbH boosted its stake in USANA Health Sciences by 8.8% in the 3rd quarter. Allianz Asset Management GmbH now owns 11,425 shares of the company’s stock worth $659,000 after purchasing an additional 920 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in USANA Health Sciences by 6.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 17,440 shares of the company’s stock worth $1,005,000 after purchasing an additional 1,055 shares in the last quarter. Institutional investors own 48.25% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/03/12/myron-w-wentz-sells-78129-shares-of-usana-health-sciences-inc-usna-stock.html.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.